SPONSOR
University of Texas Southwestern Medical Center
Total Trials
30
Recruiting
30
Phases
Phase 2, EARLY_Phase 1, Phase 4
Conditions studied: Lipid Metabolism DisorderBladder CancerUrothelial CarcinomaHematuriaSmoking CessationHeart FailureDiabetesSuicidal IdeationSuicide AttemptAnxiety
University of Texas Southwestern Medical Center is a clinical research sponsor with 30 registered studies on ClinicalTrials.gov, of which 30 are actively recruiting participants. Research covers conditions including Lipid Metabolism Disorder, Bladder Cancer, Urothelial Carcinoma, Hematuria.
The trial portfolio spans Phase 2, EARLY_Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Texas Southwestern Medical Center
How many clinical trials has University of Texas Southwestern Medical Center sponsored?
ClinicalMetric currently tracks 30 clinical trials sponsored by University of Texas Southwestern Medical Center, of which 30 are actively recruiting participants. These trials cover conditions including Lipid Metabolism Disorder, Bladder Cancer, Urothelial Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Texas Southwestern Medical Center research focus on?
University of Texas Southwestern Medical Center clinical trials span Lipid Metabolism Disorder, Bladder Cancer, Urothelial Carcinoma, Hematuria, Smoking Cessation, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Texas Southwestern Medical Center clinical trial?
To participate in a University of Texas Southwestern Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Texas Southwestern Medical Center trials with current recruitment status updated daily.
Clinical Trials by University of Texas Southwestern Medical Center
NCT05693701
Recruiting
Multicomponent Intervention Study- Blood Donors With High Cholesterol
Lipid Metabolism Disorder
NCT05646485
Recruiting
Bladder Cancer Screening Trial
Bladder Cancer
NCT06593314
Recruiting
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
Heart Failure
NCT07170657
Recruiting
Teen Recovery Through Inspiration, Support, and Empowerment
Suicidal Ideation
NCT07689175 Phase 2
Recruiting
Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
NCT07292792
Recruiting
The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services
HIV Disease
NCT06966336
Recruiting
IEEM- Work:Rest Cycles in Burn Survivors- Humidity
Hyperthermia
NCT06467708
Recruiting
Transcutaneous Auricular Neurostimulation for ICU Patients With Traumatic Brain Injury
TBI (Traumatic Brain Injury)
NCT06400550
Recruiting
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
Melanoma (Skin)
NCT06789848 Phase 2
Recruiting
Ligufalimab and Cadonilimab in Advanced Liver Cancers
Advanced Hepatocellular Carcinoma
NCT07352709
Recruiting
Ventilation Performance and Feedback Simulation Trial
Out-of-hospital Cardiac Arrest (OHCA)
NCT05028309
Recruiting
Effects of Obesity in the Aged
Obesity
NCT07032389 Phase 2
Recruiting
A Polypill for Acute Coronary Syndrome
Acute Coronary Syndrome
NCT05106036
Recruiting
Preventing Cognitive Decline by Reducing BP Target Trial
Cognitive Decline
NCT06076538
Recruiting
PET/MR for Characterization of Renal Masses (RMs)
Renal Tumor
NCT06266338 Phase 2
Recruiting
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
Cervix Cancer
NCT04838678 EARLY_Phase 1
Recruiting
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
Hypertension
NCT07430761
Recruiting
ET Stigma Response to Tremor Suppression
Action Tremor
NCT05478694
Recruiting
Outcomes of Focal Ablation for Prostate Cancer
Prostate Cancer
NCT03872102
Recruiting
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
Parkinson Disease
NCT07426016
Recruiting
Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration
Respiratory Distress Syndrome (Neonatal)
NCT07183644
Recruiting
Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
Port Wine Stains
NCT05886816 Phase 2
Recruiting
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
SARS-CoV Infection
NCT07494812
Recruiting
Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials
NPH (Normal Pressure Hydrocephalus)
NCT03621553 Phase 4
Recruiting
Vitamin D Homeostasis in Sarcoidosis
Sarcoidosis
NCT04232631
Recruiting
Non-Invasive Testing to Evaluate Wound Healing in Diabetes
Diabetic Foot Ulcer
NCT00992303
Recruiting
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Unspecified Adult Solid Tumor, Protocol Specific
NCT07113353
Recruiting
Non-Invasive ICP Monitoring Study
Intracranial Pressure
NCT04623502
Recruiting
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Kidney Cancer
NCT06130059 Phase 2
Recruiting
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
Heart Failure
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology